Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sambucus comp.
- Development stage
- Preclinical
- Lead developer
- Weleda
- Administration
- Oral
01
Overview
Sambucus comp. is a homeopathic and botanical combination product developed by Weleda and Pharma-Natura. It is formulated as oral drops containing active ingredients such as Sambucus nigra (elderberry), Berberis, Phosphorus, and Teucrium scorodonia. The product is primarily used in the treatment of postnasal drip and respiratory catarrh. As a homeopathic preparation, it does not target a single biological pathway but is intended to stimulate the body's natural healing processes. It has been evaluated in clinical studies, including those sponsored by the Department of Health, comparing its efficacy against standard care for postnasal drip.
- Brand names
- Sambucus Comp. Drops
- Other names
- Sambucus Comp.
Beyond the preview
Go deeper on Sambucus comp..
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sambucus comp..